Skip to main content

Table 3 Cox proportional hazard model for multivariate analysis of different parameters

From: ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy

A

    

Characteristics

p-value

Odds ratio

95% CI lower

95% CI upper

Menopausal status

0.176

0.854

0.177

1.465

Age at diagnosis

0.283

0.916

0.110

1.906

ER

0.454

0.809

0.191

2.233

HER-2

0.483

0.971

0.117

2.602

Triple negative status

0.128

1.006

0.213

2.834

Tumor grading

0.982

0.968

0.194

4.075

Lymph node (N+)

0.644

0.873

0.125

3.614

Pathological response to primary chemotherapy

0.043

5.274

1.388

26.173

8092A

0.048

2.690

1.091

9.053

19007C

0.031

4.177

1.226

23.131

B

    

Characteristics

p-value

Odds ratio

95% CI lower

95% CI upper

C8092 + T19007

0.430

1.266

0.334

3.231

8092A + 19007C

0.049

4.377

1.031

23.112

ER

0.332

0.793

0.143

2.655

PR

0.459

1.127

0.178

4.117

HER-2

0.139

0.699

0.166

1.223

Ki67

0.073

0.222

0.053

1.081

Pathological response to primary chemotherapy

0.051

0.565

0.136

1.377